Skip to main content
. 2022 Mar 24;14(4):700. doi: 10.3390/pharmaceutics14040700

Figure 6.

Figure 6

In vitro cell viability of raw resatorvid on (A) human transformed keratinocytes (HaCaT) and (B) primary normal human epidermal keratinocytes (NHEKs).